Antabio's Grant - IV Round

Antabio raised a round of funding on November 13, 2013. Investors include BPI France.

Antabio is a biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.…

Articles about Antabio's Grant - IV Round: